Shan Li

2.2k total citations
82 papers, 1.6k citations indexed

About

Shan Li is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Shan Li has authored 82 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 19 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Shan Li's work include Inflammatory Biomarkers in Disease Prognosis (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Shan Li is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Shan Li collaborates with scholars based in China, United Kingdom and United States. Shan Li's co-authors include Xue Qin, Qiliu Peng, Li Xie, Taijie Li, Yan Deng, Yanqiong Liu, Jinmin Zhao, Jian Wang, Zhiyu Zeng and Xianjun Lao and has published in prestigious journals such as PLoS ONE, Scientific Reports and Gene.

In The Last Decade

Shan Li

78 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shan Li China 24 397 309 261 238 192 82 1.6k
Rosaria Maddalena Ruggeri Italy 31 363 0.9× 362 1.2× 342 1.3× 166 0.7× 151 0.8× 133 2.6k
Xiaowei Zhang China 22 448 1.1× 388 1.3× 230 0.9× 129 0.5× 194 1.0× 102 1.8k
Xiao‐Mei Li China 25 446 1.1× 167 0.5× 485 1.9× 199 0.8× 136 0.7× 165 2.0k
In Joo Kim South Korea 26 479 1.2× 279 0.9× 474 1.8× 158 0.7× 316 1.6× 136 2.6k
Michiaki Abe Japan 20 310 0.8× 252 0.8× 446 1.7× 150 0.6× 162 0.8× 82 1.8k
Violetta Dziedziejko Poland 25 679 1.7× 192 0.6× 361 1.4× 120 0.5× 125 0.7× 166 2.4k
Toshiaki Nakano Japan 25 613 1.5× 373 1.2× 482 1.8× 116 0.5× 328 1.7× 203 2.5k
Gopala K. Rangan Australia 22 751 1.9× 162 0.5× 281 1.1× 117 0.5× 211 1.1× 85 2.2k
Julia Blanco Spain 28 854 2.2× 295 1.0× 292 1.1× 334 1.4× 230 1.2× 43 2.7k

Countries citing papers authored by Shan Li

Since Specialization
Citations

This map shows the geographic impact of Shan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Li more than expected).

Fields of papers citing papers by Shan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Li. The network helps show where Shan Li may publish in the future.

Co-authorship network of co-authors of Shan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Li. A scholar is included among the top collaborators of Shan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Li. Shan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shan, et al.. (2025). Reactivation mechanism of loess-mudstone historical landslide under rainfall-vibration effects. Engineering Geology. 356. 108277–108277.
4.
Bai, Xue, Shan Li, & Yan Luo. (2024). FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression. International Ophthalmology. 44(1). 55–55. 3 indexed citations
5.
Cheng, Ying, Qing Zhou, Baohui Han, et al.. (2023). NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients with metastatic non-small-cell lung cancer. Lung Cancer. 178. 87–95. 6 indexed citations
6.
Huang, Niannian, Yue Wang, Gaofeng Zhan, et al.. (2019). Contribution of skeletal muscular glycine to rapid antidepressant effects of ketamine in an inflammation-induced mouse model of depression. Psychopharmacology. 236(12). 3513–3523. 10 indexed citations
7.
Chen, Siyuan, Jin Wang, Shan Ou, et al.. (2018). Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease: A case-control study. Gene. 688. 107–118. 7 indexed citations
8.
Li, Shan, Gitali Ganguli‐Indra, & Arup K. Indra. (2016). Lipidomic analysis of epidermal lipids: a tool to predict progression of inflammatory skin disease in humans. Expert Review of Proteomics. 13(5). 451–456. 43 indexed citations
9.
Sun, Yifan, Shan Li, Xue Qin, et al.. (2015). Impact of gamma-glutamyl carboxylase gene polymorphisms on warfarin dose requirement: A systematic review and meta-analysis. Thrombosis Research. 135(4). 739–747. 26 indexed citations
10.
Lao, Xianjun, Qiliu Peng, Lu Yu, et al.. (2014). Glutathione S-transferase gene GSTM1, gene-gene interaction, and gastric cancer susceptibility: evidence from an updated meta-analysis. Cancer Cell International. 14(1). 127–127. 17 indexed citations
11.
Peng, Qiliu, Shan Li, Xue Qin, et al.. (2014). EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis. Cancer Cell International. 14(1). 134–134. 6 indexed citations
12.
Yan, Yulan, Hongjie Liang, Taijie Li, et al.. (2014). Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case–control studies. Tumor Biology. 35(3). 2687–2692. 11 indexed citations
13.
Peng, Qiliu, Shan Li, Xianjun Lao, et al.. (2014). Interleukin-12B +1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: Evidence from a meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 38(6). 735–743. 4 indexed citations
14.
Qin, Xue, Qiliu Peng, Weizhong Tang, et al.. (2013). An Updated Meta-Analysis on the Association of MDM2 SNP309 Polymorphism with Colorectal Cancer Risk. PLoS ONE. 8(9). e76031–e76031. 18 indexed citations
15.
Liu, Yanqiong, Weizhong Tang, Jian Wang, et al.. (2013). Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis. Diagnostic Pathology. 8(1). 181–181. 28 indexed citations
16.
Liang, Hongjie, Li Xie, Yu He, et al.. (2013). Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis. Tumor Biology. 35(3). 2191–2197. 10 indexed citations
17.
Qin, Xue, Qiliu Peng, Zhiping Chen, et al.. (2013). The association of interleukin-16 gene polymorphisms with IL-16 serum levels and risk of nasopharyngeal carcinoma in a Chinese population. Tumor Biology. 35(3). 1917–1924. 26 indexed citations
18.
Li, Shan, Zhiping Chen, Qiliu Peng, et al.. (2012). Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis. International Journal of Infectious Diseases. 17(1). e12–e23. 95 indexed citations
19.
Qin, Xue, Qiliu Peng, Zhiyu Zeng, et al.. (2012). Interleukin-1A −889C/T polymorphism and risk of Alzheimer’s disease: a meta-analysis based on 32 case–control studies. Journal of Neurology. 259(8). 1519–1529. 14 indexed citations
20.
Li, Shan. (2001). Short-Term Nutritional Support in Treating COPD and Respiratory Insufficiency with Severely Malnutrition. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026